cme.medlearning.de - CME Logo

Literatur

  1. Birkhead G, Attaway NJ, Strunk RC, Townsend MC, Teutsch S. Investigation of a cluster of deaths of adolescents from asthma: evidence implicating inadequate treatment and poor patient adherence with medications. J Allergy Clin Immunol 1989; 84:484-491.
  2. Jalaludin BB, Smith MA, Chey T, Orr NJ, Smith WT, Leeder SR. Risk factors for asthma deaths: a population-based, case-control study. Aust N Z J Public Health 1999; 23:595-600.
  3. National Institutes of Health, National Heart LaBI. Expert Panel Report II. Guidelines for the diagnosis and management of asthma. In. Bethesda, 1997.
  4. Global Initiative for Chronic Obstructive Lung Disease (GOLD), World Health Organization (WHO), National Heart LaBIN. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda (MD): Global Initiative for Chronic Obstructive Lung Disease. Bethesda, 2005.
  5. Berdel D, Buhl R, Dierkesmann R, et al. Nationale Versorgungs-Leitlinie Asthma, 2005.
  6. Haynes RB. Improving patient adherence: state of the art, with a special focus on medication taking for cardiovascular disorders. In: Burke LE, Ockene IS, eds. Compliance in health care and research. New York: Futura Publishing Co Inc, 2001; 3-21.
  7. Haynes R, Yao X, Degani A, et al. Interventions to enhance medication adherence. Cochrane Database Syst Rev 2005:CD000011.
  8. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-497.
  9. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. The rational clinical examination. Is this patient taking the treatment as prescribed? Jama 1993; 269:2779-2781.
  10. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. Jama 2002; 288:2868-2879.
  11. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150:1377-1378.
  12. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150:1509-1510.
  13. Urquhart J. The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet 1997; 32:345-356.
  14. Urquhart J. The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response. Br J Clin Pharmacol 2002; 54:212-220.
  15. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. Jama 2002; 288:462-467.
  16. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 2003; 6:566-573.
  17. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002; 288:2880-2883.
  18. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. Jama 2002; 288:455-461.
  19. Sackett DL, Snow JC. Compliance in health care. In. Baltimore: John Hopkins University Press, 1979; 11-22.
  20. Waeber B, Leonetti G, Kolloch R, McInnes GT. Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study. J Hypertens 1999; 17:1041-1045.
  21. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23:1296-1310.
  22. Volmer T, Kielhorn A. Compliance und Gesundheitsökonomie. In: Petermann F, ed. Compliance und Selbstmanagement. Göttingen: Hogrefe, 1998; 45-72.
  23. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36:1331-1336.
  24. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58:1126-1132.
  25. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother 1993; 27:S1-24.
  26. LaRosa JC. Poor compliance: the hidden risk factor. Curr Atheroscler Rep 2000; 2:1-4.
  27. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med 1993; 153:1863-1868.
  28. World Health Organization (WHO). Adherence to long-term therapies: evidence for action. Genf: http://www.who.int/chronic_conditions/en/adherence_report.pdf (Besucht: 16.01.2006), 2003.
  29. British Thoracic Society, Scottisch Intercollegiate Guidelines Network. Concordance and compliance. In: British guideline on the management of asthma, 2005; 59-60.
  30. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000; 117:542-550.
  31. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996; 109:963-968.
  32. Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences. Chest 2000; 117:33S-37S.
  33. Lindberg M, Ekstrom T, Moller M, Ahlner J. Asthma care and factors affecting medication compliance: the patient's point of view. Int J Qual Health Care 2001; 13:375-383.
  34. Scherman MH, Dahlgren LO, Lowhagen O. Refusing to be ill: a longitudinal study of patients' experiences of asthma/allergy. Disabil Rehabil 2002; 24:297-307.
  35. 35.            Farber HJ, Capra AM, Finkelstein JA, et al. Misunderstanding of asthma controller medications: association with nonadherence. J Asthma 2003; 40:17-25.
  36. Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995; 8:899-904.
  37. Cochrane GM, Horne R, Chanez P. Compliance in asthma. Respir Med 1999; 93:763-769.
  38. Rau JL. Determinants of patient adherence to an aerosol regimen. Respir Care 2005; 50:1346-1356; discussion 1357-1349.
  39. Petermann F, Mühlig S. Grundlagen und Möglichkeiten der Compliance-Verbesserung. In: Petermann F, ed. Compliance und Selbstmanagement. Göttingen: Hogrefe, 1998.
  40. Makoul G, Arntson P, Schofield T. Health promotion in primary care: physician-patient communication and decision making about prescription medications. Soc Sci Med 1995; 41:1241-1254.
  41. FitzGerald JM, Turner MO. Delivering asthma education to special high risk groups. Patient Educ Couns 1997; 32:S77-86.
  42. Adams S, Pill R, Jones A. Medication, chronic illness and identity: the perspective of people with asthma. Soc Sci Med 1997; 45:189-201.
  43. Petermann F, Warschburger P. Asthma und Allergie: Belastungen, Krankheitsbewältigung und Compliance. In: Schwarzer R, ed. Gesundheitspsychologie: ein Lehrbuch. Göttingen: Hogrefe, 1997; 431-454.
  44. Stewart MA. What is a successful doctor-patient interview? A study of interactions and outcomes. Soc Sci Med 1984; 19:167-175.
  45. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002:CD000011.
  46. Schraa JC, Dirks JF. Improving patient recall and comprehension of the treatment regimen. J Asthma 1982; 19:159-162.
  47. Rubin BK. What does it mean when a patient says, "my asthma medication is not working?" Chest 2004; 126:972-981.
  48. Lewis RM, Fink JB. Promoting adherence to inhaled therapy: building partnerships through patient education. Respir Care Clin N Am 2001; 7:277-301, vi.